Cancer 'smart bomb' created from a crocus

September 13, 2011 by Deborah Braconnier in Cancer report
Cancer 'smart bomb' created from a crocus

Enlarge

Colchicum autumnale autumn crocus. Image: Luc Viatour/ Wikipedia.

(PhysOrg.com) -- Scientists from the UK have figured out a way to turn chemicals found in the crocus flower which blooms throughout the UK into a ‘smart bomb’ of sorts when it comes to a new cancer medication. This new treatment may potentially create a drug that is capable of targeting cancerous tumors, such as associated with breast, colon, lung and prostate, without causing any side effects.

The researchers, from the Institute for Cancer Therapeutics at the University of Bradford, have published their work in Cancer Research and had it showcased at the recent British Science Festival.

While the native British Autumn crocus has been known for a long time for its anti-inflammatory and anti-cancer properties, its colchicine is unfortunately also toxic to other cells within the human body. For this reason, the use of the crocus and the chemical colchicine has not been used for medical treatments.

The researchers, led by Professor Laurence Patterson, have found a way around the toxic nature of the chemical when it comes to healthy tissue in the body and determined a way to focus the toxicity towards the cancerous tumor. By attaching a chemical 'tail' to the colchicine molecule, the researchers have been able to deactivate the toxic properties until it reaches the targeted cancer. Cancer tumors contain an enzyme called MMP and this enzyme effectively removes the ‘tail’ and activates the colchicine. Once activated, the colchicine goes into action breaking up the blood vessels that feed the tumor and essential starve it. Because the drug is activated in the tumor, it does not affect outside tissue and no side effects have been noted.

At this time, tests have only been conducted on mice but the results have been remarkable. In mice testing, all mice have responded to the treatment and in as many as half of the studies, the mice appeared cured of the . The drug is effective toward cancers that produce tumors and the researchers have tested breast, colon, lung, prostate and sarcoma tumors at this point.

Clinical trials on human patients are expected to being in as soon as 18 months and will be conducted at St. James’s University Hospital. The researchers hope that if the clinical trials prove successful, a new drug could be available within the next six to seven years.

© 2011 PhysOrg.com

5 /5 (15 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

antialias_physorg
Sep 13, 2011

Rank: 4.5 / 5 (2)
At this time, tests have only been conducted on mice but the results have been remarkable. In mice testing, all mice have responded to the treatment and in as many as half of the studies, the mice appeared cured of the cancer.


Woha...usually stuff like this sounds too good to be true. But in this case the simplicity and elegance of the method makes me hope that something will come of it.
Isaacsname
Sep 13, 2011

Rank: 5 / 5 (1)
" Never been used for medical treatments " ..?

I'm well familiar with Colchicine, have worked with it to induce polyploids in plants ( old school GMO's baby :).

Methinks the author of this here article needs to go crack some books.

http://en.wikiped...lchicine
fuviss_co_uk
Sep 13, 2011

Rank: not rated yet
"The researchers hope that if the clinical trials prove successful, a new drug could be available within the next six to seven years."

why so long ? ill people doesn't have a time,better is to die from the cancer or take little risk and use this new treatment now ?
antialias_physorg
Sep 13, 2011

Rank: 5 / 5 (2)
why so long ?

There's several phases which a drug will have to go through before being approved.
http://en.wikiped...al_trial
This takes considerable time.
retrosurf
Sep 14, 2011

Rank: not rated yet
colchicine:

See Gout, treatment.
roblet
Sep 19, 2011

Rank: not rated yet
You know what, I am terminally ill with a large Sarcoma in the pelvis, thorax abdomen area. I was selected for trials during my last treatment and believe me when you are this ill you are happy for any offer of help. This new s-bomb sounds amazing, so why can this not be offered for trial with peeps like me, who are basically awaiting the end. If there is no hope of cure, nothing is lost from allowing this to go ahead now. How many lives will have passed in seven years time.
Rank 5 /5 (15 votes)
Related Stories
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created 12 hours ago | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created 13 hours ago | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created 14 hours ago | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created 16 hours ago | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created 19 hours ago | popularity not rated yet | comments 1


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

First study to suggest that the immune system may protect against Alzheimer's changes in humans

Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.